DEVELOPMENT OF TARGET CHARACTERIZATION METHODS FOR NOVEL CANCER MARKERS

NIH RePORTER · NIH · N01 · $41,007,134 · view on reporter.nih.gov ↗

Abstract

Development and delivery of molecular characterization methods for newly identified cancer biomarkers.

Key facts

NIH application ID: 10281338
Project number: 75N91019D00024-0-759102000026-1
Recipient: LEIDOS BIOMEDICAL RESEARCH, INC.
Principal Investigator: ETHAN DMITROVSKY
Activity code: N01
Funding institute: NIH
Fiscal year: 2020
Award amount: $41,007,134
Award type: —
Project period: 2020-09-28 → 2025-09-27